128 related articles for article (PubMed ID: 8471557)
1. Malignant lymphoproliferative disorders in liver cirrhosis.
Lombardo L; Rota Scalabrini D; Vineis P; De La Pierre M
Ann Oncol; 1993 Mar; 4(3):245-50. PubMed ID: 8471557
[TBL] [Abstract][Full Text] [Related]
2. [Liver cirrhosis and lymphoproliferative diseases: coincidence or association?].
Lombardo L; Rota Scalabrini D; Fracchia M; Torchio B; De La Pierre M
Recenti Prog Med; 1991; 82(7-8):372-7. PubMed ID: 1947400
[TBL] [Abstract][Full Text] [Related]
3. HBsAg, chronic lymphoproliferative disorders, and cirrhosis of liver.
Heimann R; Ray MB; Desmet VJ
J Clin Pathol; 1977 Sep; 30(9):817-21. PubMed ID: 915009
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.
Idilman R; Bozkus Y; Seval G; Mizrak D; Cinar K; Ustun Y; Bektas M; Arat M; Akbulut H; Doganay B; Ozden A
J Med Virol; 2011 Jun; 83(6):974-80. PubMed ID: 21503909
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
Caviglia GP; Sciacca C; Abate ML; Olivero A; Rosso C; Touscoz GA; Ciancio A; Rizzetto M; Smedile A
J Gastroenterol Hepatol; 2015 Apr; 30(4):742-7. PubMed ID: 25351042
[TBL] [Abstract][Full Text] [Related]
6. [Liver cirrhosis and lymphoproliferative diseases].
Krel' PE; Aprosina ZG; Andreeva NE; Suvorova EV; Popova IV; Serov VV
Ter Arkh; 1992; 64(6):46-53. PubMed ID: 1440337
[TBL] [Abstract][Full Text] [Related]
7. Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? An age-period-cohort analysis on Norwegian data from 1953 to 1997.
Thu GO; Hem LY; Hansen S; Møller B; Norstein J; Nøkleby H; Grotmol T
Int J Cancer; 2006 Apr; 118(8):2035-9. PubMed ID: 16287082
[TBL] [Abstract][Full Text] [Related]
8. [Lymphoproliferative disorders in an inflammatory bowel disease unit].
Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E
Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478
[TBL] [Abstract][Full Text] [Related]
9. Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.
Naparstek J; Eliakim M
Am J Dig Dis; 1978 Oct; 23(10):887-92. PubMed ID: 717348
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
Hézode C; Duvoux C; Germanidis G; Roudot-Thoraval F; Vincens AL; Gaulard P; Cherqui D; Pawlotsky JM; Dhumeaux D
Hepatology; 1999 Sep; 30(3):775-8. PubMed ID: 10462385
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disease in liver transplantation.
Dhillon MS; Rai JK; Gunson BK; Olliff S; Olliff J
Br J Radiol; 2007 May; 80(953):337-46. PubMed ID: 17392399
[TBL] [Abstract][Full Text] [Related]
13. The changing incidence of lymphoproliferative disorders in Yorkshire.
Jack AS; Morgan GJ; Clayden D; McNally R; Thomas J; Cartwright R
Clin Lab Haematol; 1998 Oct; 20(5):289-95. PubMed ID: 9807676
[TBL] [Abstract][Full Text] [Related]
14. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL
Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407
[TBL] [Abstract][Full Text] [Related]
16. Presence of human herpesvirus 8 (HHV-8) DNA sequences in patients with lymphoproliferative diseases and chronic blood disorders.
Keyvani H; Karbalaie Niya MH; Esghaei M; Bokharaei-Salim F; Monavari SHR
Microb Pathog; 2017 Oct; 111():431-434. PubMed ID: 28916317
[TBL] [Abstract][Full Text] [Related]
17. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
18. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
McLaughlin K; Wajstaub S; Marotta P; Adams P; Grant DR; Wall WJ; Jevnikar AM; Rizkalla KS
Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
[TBL] [Abstract][Full Text] [Related]
19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis.
Lombardo L; Capaldi A; Poccardi G; Vineis P
Int J Clin Lab Res; 1995; 25(3):153-6. PubMed ID: 8562979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
